Overview

Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The trial attempts to optimize, standardize and simplify the characteristic diagnosis and treatment program of the dominant diseases in our hospital-the sequelae of pelvic inflammatory disease, so as to make it suitable for clinical diagnosis and treatment in primary hospital.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Criteria
Inclusion Criteria:

1. Patients with diagnostic criteria for the sequelae of pelvic inflammatory disease in
Western medicine;

2. Patients conforming to the criteria of TCM syndrome differentiation;

3. Age 18--60 years old, married or sexual life;

4. In this study, the voluntary participation, and signed informed consent;

Exclusion Criteria:

1. Patients who do not meet the diagnostic criteria of Western medicine and traditional
Chinese medicine dialectical typing standard;

2. Persons with acute pelvic inflammatory disease;

3. Related symptoms caused by diseasesGynecological tumor,specific vaginitis, acute
cervicitis, pelvic congestion syndrome, endometriosis, adenomyosis, pelvic
tuberculosis etc.

4. Pregnant and lactating women;

5. With severe primary disease, such as liver, kidney, heart, brain and hematopoietic
system;

6. Allergic to a variety of drugs or known to be allergic to the composition of the use
of traditional Chinese Medicine;

7. Patients taking part in other clinical trials;

8. Suspect or do have a history of alcohol, drug abuse or according to the judgment of
the researcher,other lesions or circumstances that have reduced the likelihood of
entering a group or the complexity of entering a group,such as frequent changes in the
working environment, the living environment is not stable,etc.